The Pharma Letter1d
The week in pharma: action, reaction and insight – week to January 10
Among significant news last week, the US Food and Drug Administration (FDA) required Agios Pharmaceuticals to amend the label ...
Taiwan News5d
60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) Babesiosis
Physicians or patients who wish to participate in the 60 Degrees Pharmaceuticals Tafenoquine for Babesiosis Expanded Access clinical study are encouraged to visit the Company’s website for information ...
The Pharma Letter6d
FDA liver injury warning label for Agios' Pyrukynd
Administration (FDA) approved an update to the US Prescribing Information (USPI) for Pyrukynd (mitapivat) for the treatment ...
Frontiers25d
Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial
Six female and four male patients completed the study. One patient received rituximab previously for treatment of autoimmune hemolytic anemia more than 12 months ago (Table 1). Based on these results, ...
Healthline27d
Can Drinking Too Much Cow’s Milk Cause Anemia in Babies and Toddlers?
When you don’t get enough iron, you can develop iron deficiency anemia (IDA). In IDA, you cannot make enough healthy red blood cells to carry oxygen throughout your body. There are many ...
Healthline27d
Anemia in Chronic Kidney Disease: Treatment and More
Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life. It’s ...